RMEI is dedicated to providing cutting-edge continuing education opportunities for healthcare professionals in order to promote knowledge, awareness, and best practices. We present CME resources in a wide variety of therapeutic areas and formats designed to be both effective and efficient. Most of our activities provide CME credits for physicians and some offer credit for non-physicians. Visit the links on the menu to view upcoming opportunities or click Therapeutic Areas above to view activities in your desired content area.

Clinical Convergence®: Approaching Chronic Urticaria from the Patient Perspective

This activity is designed to engage your critical thinking and challenge suboptimal approaches to patient care. It features videos of 2 patients with chronic urticaria (CU) and challenging interactive questions related to their histories and treatments. You will have an opportunity to hear the patients’ perspectives of CU, and learn from our expert faculty.

Clinical Exchanges®: Detangling Difficult Conversations About Multiple Sclerosis

This conversation-centered activity with educational pearls takes learners through a clinical exchange between patients with multiple sclerosis and their providers.

Clinical Reflections®: Multiple Sclerosis Diagnosis and Management Strategies

Discover scenarios of patients with multiple sclerosis followed by assessment and management questions that explore how the patients can be managed optimally.

 

Clinical Reflections®: Reflecting on Errors and Missed Opportunities in Chronic Urticaria

This unique educational initiative harnesses the power of reflection and recognition of suboptimal approaches to patient care to allow you to rethink clinical decisions based on the scenarios presented, and to modify treatment plans accordingly. You can compare your responses to interactive questions with those of your peers and learn from our expert faculty.

Combating Residual Risk with Treatment Intensification: Focus on PCSK9 Inhibitors - A Care Team Forum℠

The panel will delve into topics covering safety/efficacy data for PCSK9 inhibitors (PCSK9-Is), 2018 ACC/AHA guideline updates, and patient selection for treatment intensification with PCSK9-Is. Faculty will examine key matters in patient care, provide illustrative patient case scenarios, pose practical solutions to common issues encountered in clinical practice, and Charles will provide insight into his experience with familial hypercholesterolemia, its treatment, and his interaction with the healthcare system.

 

 

Experts-in-the-Hot Seat: Emerging Trends in Managing Hemophilia A

In this CME activity, you will hear insights from 3 hemophilia experts on the current management approach to hemophilia A with and without inhibitors, new developments in hemophilia A therapies, and ways to incorporate shared decision making when treating patients with hemophilia A. In addition, you will have an opportunity to practice through a series of questions and compare yourself to your peers.

 

IBD in Clinical Practice: Diagnosis and Medical Treatment 2019

Join leading inflammatory bowel disease (IBD) experts in this interactive activity where you will have the opportunity to follow a patient to learn about the diagnosis and management of IBD. Be sure to check out the Crohn's & Colitis Foundation resources as well as a comprehensive reading list related to the learning objectives following the closing commentary section of the activity.

 

IBD in Clinical Practice: Long-term Disease Management and Surgery - 2019

Join leading inflammatory bowel disease (IBD) experts in this interactive activity where you will have the opportunity to follow a patient to learn about the long-term management and surgery indications of IBD. Be sure to check out the Crohn's & Colitis Foundation resources as well as a comprehensive reading list related to the learning objectives following the closing commentary section of the activity.

 

Integration of Immunotherapy into Treatment for Hematological Malignancies

This enduring activity will provide learners with the latest developments in immunotherapy for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.

Obtaining Authorization for PCSK9 Inhibitors: A Care Team Forum

In this interactive roundtable discussion, Charles, his doctor, and 2 other prominent clinical experts gather to deliberate over reimbursement issues surrounding the clinical use of PCSK9-Is and offer practical strategies to facilitate navigating the prior authorization and appeals process.